Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Comparison of various methods for quantification of equine insulin under clinical settings for assessment of insulin dysregulation / / Tobias Warnken
| Comparison of various methods for quantification of equine insulin under clinical settings for assessment of insulin dysregulation / / Tobias Warnken |
| Autore | Warnken Tobias |
| Pubbl/distr/stampa | Göttingen : , : Cuvillier Verlag, , [2019] |
| Descrizione fisica | 1 online resource (141 pages) |
| Disciplina | 616.46207 |
| Soggetto topico | Insulin resistance |
| ISBN | 3-7369-6124-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910795385803321 |
Warnken Tobias
|
||
| Göttingen : , : Cuvillier Verlag, , [2019] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Comparison of various methods for quantification of equine insulin under clinical settings for assessment of insulin dysregulation / / Tobias Warnken
| Comparison of various methods for quantification of equine insulin under clinical settings for assessment of insulin dysregulation / / Tobias Warnken |
| Autore | Warnken Tobias |
| Pubbl/distr/stampa | Göttingen : , : Cuvillier Verlag, , [2019] |
| Descrizione fisica | 1 online resource (141 pages) |
| Disciplina | 616.46207 |
| Soggetto topico | Insulin resistance |
| ISBN | 3-7369-6124-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910815691603321 |
|
Warnken Tobias
|
||
| Göttingen : , : Cuvillier Verlag, , [2019] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Evolving Concepts in Insulin Resistance / / edited by Marco Infante
| Evolving Concepts in Insulin Resistance / / edited by Marco Infante |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2022 |
| Descrizione fisica | 1 online resource (ix, 190 pages) : illustrations |
| Disciplina | 616.46207 |
| Soggetto topico | Insulin resistance |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. The Insulin Journey in the Human Body -- 2. Insulin Receptor Isoforms in Physiology and Metabolic Disease -- 3. Molecular Mechanisms Involved in Insulin Resistance: Recent Updates and Future Challenges -- 4. Mechanisms of Insulin Resistance during Pregnancy -- 5. Dietary Activation of AMP-Activated Protein Kinase (AMPK) to Treat Insulin Resistance -- 6. Cardiac Natriuretic Peptide System: A Link between Adipose Tissue, Obesity, and Insulin Resistance -- 7. Berardinelli-Seip Syndrome: Report of an Old Case Successfully Treated with Anti-Glucocorticoid Therapy Followed by Bilateral Adrenalectomy. |
| Record Nr. | UNINA-9910647495403321 |
| London : , : IntechOpen, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Evolving Concepts in Insulin Resistance / / Marco Infante, editor
| Evolving Concepts in Insulin Resistance / / Marco Infante, editor |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2022 |
| Descrizione fisica | 1 online resource (190 pages) |
| Disciplina | 616.399 |
| Soggetto topico |
Insulin resistance
Metabolic syndrome |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. The Insulin Journey in the Human Body -- 2. Insulin Receptor Isoforms in Physiology and Metabolic Disease -- 3. Molecular Mechanisms Involved in Insulin Resistance: Recent Updates and Future Challenges -- 4. Mechanisms of Insulin Resistance during Pregnancy -- 5. Dietary Activation of AMP-Activated Protein Kinase (AMPK) to Treat Insulin Resistance -- 6. Cardiac Natriuretic Peptide System: A Link between Adipose Tissue, Obesity, and Insulin Resistance -- 7. Berardinelli-Seip Syndrome: Report of an Old Case Successfully Treated with Anti-Glucocorticoid Therapy Followed by Bilateral Adrenalectomy. |
| Record Nr. | UNINA-9910687980503321 |
| London : , : IntechOpen, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Glucose homeostasis and insulin resistance [[electronic resource] /] / Leszek Szablewski
| Glucose homeostasis and insulin resistance [[electronic resource] /] / Leszek Szablewski |
| Autore | Szablewski Leszek |
| Pubbl/distr/stampa | [Saif Zone, Sharjah, United Arab Emirates], : Bentham Science Publishers Ltd., [2011] |
| Descrizione fisica | 1 online resource (217 p.) |
| Disciplina | 618.92/462 |
| Soggetto topico |
Insulin resistance
Type 2 diabetes Glucose - Metabolism |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-60805-189-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 01 Cover Page.pdf; 02 Title Page; 03 eBooks End User License Agreement-Website; 04 CONTENTS; 05 FOREWORD; 06 PREFACE; 07 Chapter 1; 08 Chapter 2; 09 Chapter 3; 10 Chapter 4; 11 Chapter 5; 12 Index |
| Altri titoli varianti | Glucose homeostasis & insulin resistance |
| Record Nr. | UNINA-9910457240803321 |
|
Szablewski Leszek
|
||
| [Saif Zone, Sharjah, United Arab Emirates], : Bentham Science Publishers Ltd., [2011] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Glucose homeostasis and insulin resistance [[electronic resource] /] / Leszek Szablewski
| Glucose homeostasis and insulin resistance [[electronic resource] /] / Leszek Szablewski |
| Autore | Szablewski Leszek |
| Pubbl/distr/stampa | [Saif Zone, Sharjah, United Arab Emirates], : Bentham Science Publishers Ltd., [2011] |
| Descrizione fisica | 1 online resource (217 p.) |
| Disciplina | 618.92/462 |
| Soggetto topico |
Insulin resistance
Type 2 diabetes Glucose - Metabolism |
| ISBN | 1-60805-189-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 01 Cover Page.pdf; 02 Title Page; 03 eBooks End User License Agreement-Website; 04 CONTENTS; 05 FOREWORD; 06 PREFACE; 07 Chapter 1; 08 Chapter 2; 09 Chapter 3; 10 Chapter 4; 11 Chapter 5; 12 Index |
| Altri titoli varianti | Glucose homeostasis & insulin resistance |
| Record Nr. | UNINA-9910781683203321 |
|
Szablewski Leszek
|
||
| [Saif Zone, Sharjah, United Arab Emirates], : Bentham Science Publishers Ltd., [2011] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Glucose homeostasis and insulin resistance / / Leszek Szablewski
| Glucose homeostasis and insulin resistance / / Leszek Szablewski |
| Autore | Szablewski Leszek |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | [Saif Zone, Sharjah, United Arab Emirates], : Bentham Science Publishers Ltd., [2011] |
| Descrizione fisica | 1 online resource (217 p.) |
| Disciplina | 618.92/462 |
| Soggetto topico |
Insulin resistance
Non-insulin-dependent diabetes Glucose - Metabolism |
| ISBN | 1-60805-189-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 01 Cover Page.pdf; 02 Title Page; 03 eBooks End User License Agreement-Website; 04 CONTENTS; 05 FOREWORD; 06 PREFACE; 07 Chapter 1; 08 Chapter 2; 09 Chapter 3; 10 Chapter 4; 11 Chapter 5; 12 Index |
| Altri titoli varianti | Glucose homeostasis & insulin resistance |
| Record Nr. | UNINA-9910815587903321 |
|
Szablewski Leszek
|
||
| [Saif Zone, Sharjah, United Arab Emirates], : Bentham Science Publishers Ltd., [2011] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Insulin resistance [[electronic resource] ] : a clinical handbook / / Andrew J. Krentz
| Insulin resistance [[electronic resource] ] : a clinical handbook / / Andrew J. Krentz |
| Autore | Krentz Andrew J |
| Pubbl/distr/stampa | Oxford ; ; Malden, Mass., : Blackwell Science, c2002 |
| Descrizione fisica | 1 online resource (202 p.) |
| Disciplina | 616.4/6207 |
| Soggetto topico | Insulin resistance |
| ISBN |
1-282-12300-9
9786612123009 0-470-69892-6 0-470-69838-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Insulin Resistance A Clinical Handbook; Contents; Preface; About the author; Acknowledgements; 1 Pathophysiology of insulin resistance; 1.1 Introduction; 1.2 Normal physiology; 1.2.1 Hormonal regulation of metabolism; 1.2.2 The insulin receptor; 1.2.3 Post-binding events; 1.2.4 Glucose metabolism; 1.2.5 Lipid metabolism; 1.2.6 Protein metabolism; 1.2.7 Ion transport; 1.3 The concept of insulin resistance; 1.3.1 Early studies of insulin action; 1.3.2 Radioimmunoassays for insulin; 1.4 Definitions of insulin resistance; 1.5 Assessment of insulin action in vivo
1.5.1 Fasting insulin concentration1.5.2 Dynamic techniques-endogenous insulin; 1.5.3 Dynamic techniques-exogenous insulin; 1.5.4 Mathematical modelling techniques; 1.5.5 Insulin suppression test; 1.5.6 Hyperinsulinaemic euglycaemic clamp technique; 1.5.7 Complementary techniques; 1.6 Mechanisms of insulin resistance; 1.6.1 Genetic defects; 1.6.2 Acquired forms of insulin resistance; 1.6.3 Fetal origins hypothesis; 1.7 Further reading; 2 Insulin resistance in clinical medicine; 2.1 Clinical features; 2.2 Factors influencing insulin sensitivity; 2.2.1 Normal variation in insulin action 2.2.2 Sex2.2.3 Age; 2.2.4 Physical exercise; 2.2.5 Tobacco; 2.2.6 Alcohol; 2.3 Physiological states of insulin resistance; 2.3.1 Puberty; 2.3.2 Pregnancy; 2.3.3 Menstrual cycle; 2.3.4 The menopause; 2.4 Severe insulin-resistance syndromes; 2.5 Insulin resistance and cardiovascular risk; 2.5.1 Syndrome X; 2.5.2 Obesity; 2.5.3 Regional adiposity; 2.5.4 Impaired glucose tolerance; 2.5.5 Type 2 diabetes mellitus; 2.5.6 Essential hypertension; 2.5.7 Dyslipidaemia; 2.5.8 Endothelial dysfunction; 2.5.9 Microalbuminuria; 2.5.10 Hyperuricaemia; 2.5.11 Impaired fibrinolysis 2.5.12 Polycystic ovary syndrome2.5.13 Non-alcoholic steatohepatitis; 2.6 Other disorders associated with insulin resistance; 2.6.1 Counter-regulatory hormone secretion; 2.6.2 Endocrinopathies; 2.6.3 Chronic renal failure; 2.6.4 Hepatic cirrhosis; 2.6.5 Cardiac failure; 2.7 Miscellaneous inherited disorders; 2.8 Drug-induced insulin resistance; 2.9 Further reading; 3 Management of insulin resistance and associated conditions; 3.1 Non-pharmacological measures; 3.1.1 Medical nutrition therapy; 3.1.2 Physical activity; 3.1.3 Alcohol; 3.1.4 Tobacco; 3.2 Drugs for type 2 diabetes; 3.2.1 Biguanides 3.2.2 Thiazolidinediones3.2.3 Sulphonylureas; 3.2.4 Meglitinide analogues; 3.2.5 α-Glucosidase inhibitors; 3.2.6 Insulin; 3.3 Antiobesity drugs; 3.3.1 Sibutramine; 3.3.2 Orlistat; 3.3.3 Leptin; 3.2.4 β3-adrenocepter agonists; 3.4 Lipid-modifying drugs; 3.4.1 Fibric acid derivatives; 3.4.2 Acipimox; 3.4.3 Statins; 3.4.4 Omega-3 fatty acids; 3.5 Antihypertensive drugs; 3.2.4 β-adrenocepter agonists; 3.5.2 Calcium-channel blockers; 3.5.3 Angiotensin converting enzyme inhibitors; 3.5.4 Angiotensin II receptor antagonists; 3.5.5 α1-Receptor blockers; 3.5.6 Selective imidazoline receptor agonists 3.5.7 Aspirin |
| Record Nr. | UNINA-9910144678003321 |
|
Krentz Andrew J
|
||
| Oxford ; ; Malden, Mass., : Blackwell Science, c2002 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Insulin resistance [[electronic resource] ] : a clinical handbook / / Andrew J. Krentz
| Insulin resistance [[electronic resource] ] : a clinical handbook / / Andrew J. Krentz |
| Autore | Krentz Andrew J |
| Pubbl/distr/stampa | Oxford ; ; Malden, Mass., : Blackwell Science, c2002 |
| Descrizione fisica | 1 online resource (202 p.) |
| Disciplina | 616.4/6207 |
| Soggetto topico | Insulin resistance |
| ISBN |
1-282-12300-9
9786612123009 0-470-69892-6 0-470-69838-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Insulin Resistance A Clinical Handbook; Contents; Preface; About the author; Acknowledgements; 1 Pathophysiology of insulin resistance; 1.1 Introduction; 1.2 Normal physiology; 1.2.1 Hormonal regulation of metabolism; 1.2.2 The insulin receptor; 1.2.3 Post-binding events; 1.2.4 Glucose metabolism; 1.2.5 Lipid metabolism; 1.2.6 Protein metabolism; 1.2.7 Ion transport; 1.3 The concept of insulin resistance; 1.3.1 Early studies of insulin action; 1.3.2 Radioimmunoassays for insulin; 1.4 Definitions of insulin resistance; 1.5 Assessment of insulin action in vivo
1.5.1 Fasting insulin concentration1.5.2 Dynamic techniques-endogenous insulin; 1.5.3 Dynamic techniques-exogenous insulin; 1.5.4 Mathematical modelling techniques; 1.5.5 Insulin suppression test; 1.5.6 Hyperinsulinaemic euglycaemic clamp technique; 1.5.7 Complementary techniques; 1.6 Mechanisms of insulin resistance; 1.6.1 Genetic defects; 1.6.2 Acquired forms of insulin resistance; 1.6.3 Fetal origins hypothesis; 1.7 Further reading; 2 Insulin resistance in clinical medicine; 2.1 Clinical features; 2.2 Factors influencing insulin sensitivity; 2.2.1 Normal variation in insulin action 2.2.2 Sex2.2.3 Age; 2.2.4 Physical exercise; 2.2.5 Tobacco; 2.2.6 Alcohol; 2.3 Physiological states of insulin resistance; 2.3.1 Puberty; 2.3.2 Pregnancy; 2.3.3 Menstrual cycle; 2.3.4 The menopause; 2.4 Severe insulin-resistance syndromes; 2.5 Insulin resistance and cardiovascular risk; 2.5.1 Syndrome X; 2.5.2 Obesity; 2.5.3 Regional adiposity; 2.5.4 Impaired glucose tolerance; 2.5.5 Type 2 diabetes mellitus; 2.5.6 Essential hypertension; 2.5.7 Dyslipidaemia; 2.5.8 Endothelial dysfunction; 2.5.9 Microalbuminuria; 2.5.10 Hyperuricaemia; 2.5.11 Impaired fibrinolysis 2.5.12 Polycystic ovary syndrome2.5.13 Non-alcoholic steatohepatitis; 2.6 Other disorders associated with insulin resistance; 2.6.1 Counter-regulatory hormone secretion; 2.6.2 Endocrinopathies; 2.6.3 Chronic renal failure; 2.6.4 Hepatic cirrhosis; 2.6.5 Cardiac failure; 2.7 Miscellaneous inherited disorders; 2.8 Drug-induced insulin resistance; 2.9 Further reading; 3 Management of insulin resistance and associated conditions; 3.1 Non-pharmacological measures; 3.1.1 Medical nutrition therapy; 3.1.2 Physical activity; 3.1.3 Alcohol; 3.1.4 Tobacco; 3.2 Drugs for type 2 diabetes; 3.2.1 Biguanides 3.2.2 Thiazolidinediones3.2.3 Sulphonylureas; 3.2.4 Meglitinide analogues; 3.2.5 α-Glucosidase inhibitors; 3.2.6 Insulin; 3.3 Antiobesity drugs; 3.3.1 Sibutramine; 3.3.2 Orlistat; 3.3.3 Leptin; 3.2.4 β3-adrenocepter agonists; 3.4 Lipid-modifying drugs; 3.4.1 Fibric acid derivatives; 3.4.2 Acipimox; 3.4.3 Statins; 3.4.4 Omega-3 fatty acids; 3.5 Antihypertensive drugs; 3.2.4 β-adrenocepter agonists; 3.5.2 Calcium-channel blockers; 3.5.3 Angiotensin converting enzyme inhibitors; 3.5.4 Angiotensin II receptor antagonists; 3.5.5 α1-Receptor blockers; 3.5.6 Selective imidazoline receptor agonists 3.5.7 Aspirin |
| Record Nr. | UNISA-996201270803316 |
|
Krentz Andrew J
|
||
| Oxford ; ; Malden, Mass., : Blackwell Science, c2002 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Insulin resistance : a clinical handbook / / Andrew J. Krentz
| Insulin resistance : a clinical handbook / / Andrew J. Krentz |
| Autore | Krentz Andrew J |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Oxford ; ; Malden, Mass., : Blackwell Science, c2002 |
| Descrizione fisica | 1 online resource (202 p.) |
| Disciplina | 616.4/6207 |
| Soggetto topico | Insulin resistance |
| ISBN |
1-282-12300-9
9786612123009 0-470-69892-6 0-470-69838-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Insulin Resistance A Clinical Handbook; Contents; Preface; About the author; Acknowledgements; 1 Pathophysiology of insulin resistance; 1.1 Introduction; 1.2 Normal physiology; 1.2.1 Hormonal regulation of metabolism; 1.2.2 The insulin receptor; 1.2.3 Post-binding events; 1.2.4 Glucose metabolism; 1.2.5 Lipid metabolism; 1.2.6 Protein metabolism; 1.2.7 Ion transport; 1.3 The concept of insulin resistance; 1.3.1 Early studies of insulin action; 1.3.2 Radioimmunoassays for insulin; 1.4 Definitions of insulin resistance; 1.5 Assessment of insulin action in vivo
1.5.1 Fasting insulin concentration1.5.2 Dynamic techniques-endogenous insulin; 1.5.3 Dynamic techniques-exogenous insulin; 1.5.4 Mathematical modelling techniques; 1.5.5 Insulin suppression test; 1.5.6 Hyperinsulinaemic euglycaemic clamp technique; 1.5.7 Complementary techniques; 1.6 Mechanisms of insulin resistance; 1.6.1 Genetic defects; 1.6.2 Acquired forms of insulin resistance; 1.6.3 Fetal origins hypothesis; 1.7 Further reading; 2 Insulin resistance in clinical medicine; 2.1 Clinical features; 2.2 Factors influencing insulin sensitivity; 2.2.1 Normal variation in insulin action 2.2.2 Sex2.2.3 Age; 2.2.4 Physical exercise; 2.2.5 Tobacco; 2.2.6 Alcohol; 2.3 Physiological states of insulin resistance; 2.3.1 Puberty; 2.3.2 Pregnancy; 2.3.3 Menstrual cycle; 2.3.4 The menopause; 2.4 Severe insulin-resistance syndromes; 2.5 Insulin resistance and cardiovascular risk; 2.5.1 Syndrome X; 2.5.2 Obesity; 2.5.3 Regional adiposity; 2.5.4 Impaired glucose tolerance; 2.5.5 Type 2 diabetes mellitus; 2.5.6 Essential hypertension; 2.5.7 Dyslipidaemia; 2.5.8 Endothelial dysfunction; 2.5.9 Microalbuminuria; 2.5.10 Hyperuricaemia; 2.5.11 Impaired fibrinolysis 2.5.12 Polycystic ovary syndrome2.5.13 Non-alcoholic steatohepatitis; 2.6 Other disorders associated with insulin resistance; 2.6.1 Counter-regulatory hormone secretion; 2.6.2 Endocrinopathies; 2.6.3 Chronic renal failure; 2.6.4 Hepatic cirrhosis; 2.6.5 Cardiac failure; 2.7 Miscellaneous inherited disorders; 2.8 Drug-induced insulin resistance; 2.9 Further reading; 3 Management of insulin resistance and associated conditions; 3.1 Non-pharmacological measures; 3.1.1 Medical nutrition therapy; 3.1.2 Physical activity; 3.1.3 Alcohol; 3.1.4 Tobacco; 3.2 Drugs for type 2 diabetes; 3.2.1 Biguanides 3.2.2 Thiazolidinediones3.2.3 Sulphonylureas; 3.2.4 Meglitinide analogues; 3.2.5 α-Glucosidase inhibitors; 3.2.6 Insulin; 3.3 Antiobesity drugs; 3.3.1 Sibutramine; 3.3.2 Orlistat; 3.3.3 Leptin; 3.2.4 β3-adrenocepter agonists; 3.4 Lipid-modifying drugs; 3.4.1 Fibric acid derivatives; 3.4.2 Acipimox; 3.4.3 Statins; 3.4.4 Omega-3 fatty acids; 3.5 Antihypertensive drugs; 3.2.4 β-adrenocepter agonists; 3.5.2 Calcium-channel blockers; 3.5.3 Angiotensin converting enzyme inhibitors; 3.5.4 Angiotensin II receptor antagonists; 3.5.5 α1-Receptor blockers; 3.5.6 Selective imidazoline receptor agonists 3.5.7 Aspirin |
| Record Nr. | UNINA-9910806296203321 |
|
Krentz Andrew J
|
||
| Oxford ; ; Malden, Mass., : Blackwell Science, c2002 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Insulin resistance
(21)
- Fatty liver (5)
- Glucose - Metabolism (3)
- Type 2 diabetes (2)
- Insulinorésistance (1)